Understand how pharmaceutical and biotechnology companies acquire products, technologies, royalty interests and other strategic assets using intelligence from 891 real-world transactions.
Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019-2026 provides comprehensive intelligence on 891 asset purchase transactions across the global life sciences industry.
Asset acquisitions provide companies with a targeted alternative to licensing or full corporate acquisition. Rather than acquiring an entire business, companies can purchase specific products, technologies, intellectual property, royalty interests or other assets that support pipeline development, portfolio expansion or strategic repositioning.
These transactions can vary substantially in structure. Consideration may include upfront payments, deferred or contingent payments, milestones, royalties or other ongoing economic participation, while responsibility for development, commercialization, intellectual property and transition may also form part of the agreement.
The report brings this activity together in one resource, enabling users to understand which assets companies are acquiring, who is most active, how transactions are structured, what financial terms have been disclosed and how comparable acquisitions have been documented in practice.
Rather than simply providing a list of transactions, the report combines market-wide acquisition analysis with financial benchmarking, active dealmaker intelligence, detailed transaction records and access to publicly available contract documents where available.
It provides a practical intelligence and benchmarking resource for corporate development, business development, licensing, portfolio strategy, valuation, finance, legal and senior management teams involved in evaluating, structuring or negotiating asset acquisitions.
This provides more meaningful precedent intelligence than treating headline transaction values as standalone benchmarks.
Identify comparable asset acquisitions, active buyers and relevant transaction structures.
Business Development and Licensing teams
Evaluate asset purchase opportunities alongside licensing and other partnering alternatives.
Portfolio Strategy teams
Understand how companies use targeted asset acquisitions and divestments to reshape portfolios.
Companies Considering Asset Divestment
Identify organizations with a demonstrated appetite for comparable products, technologies or royalty interests.
Valuation and Finance teams
Investigate disclosed transaction economics and relevant precedent deals to support internal assessment.
Competitive and Market Intelligence teams
Track which assets companies are acquiring and how competitors are using asset purchases to strengthen portfolios.
Legal and Transaction teams
Review publicly available asset purchase agreements and precedent provisions to support transaction preparation and negotiation.
The briefing applies the underlying asset purchase intelligence to the customer's own acquisition, divestment, product or portfolio objectives.
Depending on requirements, this can include relevant comparable transactions, prospective buyers or sellers, competitor acquisition activity, asset-type analysis, financial benchmarks, contract insights and other intelligence selected specifically for the client's situation.
Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019-2026 provides comprehensive intelligence on 891 asset purchase transactions across the global life sciences industry.
Asset acquisitions provide companies with a targeted alternative to licensing or full corporate acquisition. Rather than acquiring an entire business, companies can purchase specific products, technologies, intellectual property, royalty interests or other assets that support pipeline development, portfolio expansion or strategic repositioning.
These transactions can vary substantially in structure. Consideration may include upfront payments, deferred or contingent payments, milestones, royalties or other ongoing economic participation, while responsibility for development, commercialization, intellectual property and transition may also form part of the agreement.
The report brings this activity together in one resource, enabling users to understand which assets companies are acquiring, who is most active, how transactions are structured, what financial terms have been disclosed and how comparable acquisitions have been documented in practice.
Rather than simply providing a list of transactions, the report combines market-wide acquisition analysis with financial benchmarking, active dealmaker intelligence, detailed transaction records and access to publicly available contract documents where available.
It provides a practical intelligence and benchmarking resource for corporate development, business development, licensing, portfolio strategy, valuation, finance, legal and senior management teams involved in evaluating, structuring or negotiating asset acquisitions.
Understand the asset purchase landscape
The report analyzes asset purchase dealmaking from 2019 to 2026, including:
- Trends in asset acquisition activity by year
- Phase of development at the time of transaction
- Industry sector
- Therapy area
- Technology type
- Most active asset acquisition dealmakers
- Leading transactions by disclosed value
- Types of assets being acquired
- Reasons companies use asset purchase structures
The report distinguishes activity involving areas including:
- Business assets
- Product assets
- Royalty assets
- Technology assets
Understand how asset purchase agreements are structured
Asset purchase transactions require detailed definition of what is being transferred, what rights and liabilities remain with each party and how consideration is structured.Depending on the transaction and available disclosure, users can investigate areas including:
- Assets being transferred
- Intellectual property rights
- Product and technology rights
- Development rights and obligations
- Commercialization responsibilities
- Manufacturing and supply
- Regulatory responsibilities
- Transitional arrangements
- Upfront consideration
- Deferred or contingent payments
- Milestone payments
- Royalty or ongoing economic participation
- Representations and warranties
- Closing conditions
- Termination provisions
Benchmark leading transactions and disclosed financial terms
The report identifies leading asset purchase transactions by disclosed value and provides access to available financial information associated with individual deals.Depending on the transaction, users can investigate:
- Upfront purchase consideration
- Deferred payments
- Development milestones
- Regulatory milestones
- Commercial milestones
- Royalty arrangements
- Ongoing economic participation
- Other disclosed consideration
This provides more meaningful precedent intelligence than treating headline transaction values as standalone benchmarks.
Identify relevant comparable asset acquisitions
Finding relevant precedent transactions is an important part of evaluating an asset purchase opportunity.The report enables users to investigate transactions according to factors including:
- Asset type
- Company
- Therapy area
- Technology
- Development stage
- Transaction value
- Financial structure
- Contract availability
Identify leading asset acquisition dealmakers
The report identifies the Top 25 most active asset purchase dealmakers and provides transaction histories that enable users to investigate their previous activity.This can help users identify:
- Companies actively acquiring individual assets
- Organizations repeatedly purchasing products or technologies
- Companies acquiring royalty interests
- Dealmakers active within particular therapeutic or technology areas
- Competitors using asset acquisitions to strengthen portfolios
- Potential buyers for divestible or non-core assets
- Relevant precedent transactions
Support portfolio strategy and asset divestment
Asset purchase intelligence is useful not only to prospective buyers but also to companies considering divestment or monetization of an asset.The report enables users to investigate:
- Which types of assets are attracting buyers
- Companies actively acquiring products or technologies
- Transactions involving non-core or divested assets
- How asset sales have been structured
- Financial consideration used in comparable transactions
- How companies have retained or transferred future economic participation
Learn from real-world asset purchase agreements
Where publicly available, the report provides access to underlying contract documents for selected asset purchase transactions.These agreements can provide substantially more detail than company announcements alone, enabling users to examine how parties have documented matters including:
- Definition and transfer of assets
- Intellectual property rights
- Assumed and retained liabilities
- Purchase consideration
- Milestone and royalty provisions
- Development and commercialization obligations
- Technology transfer
- Representations and warranties
- Closing conditions
- Termination provisions
Comprehensive asset purchase deal directory
The report includes a comprehensive directory of 891 pharmaceutical and biotechnology asset purchase transactions, providing an extensive resource for identifying relevant precedent deals, active buyers and comparable assets.Deals can be investigated by:
- Company
- Therapy area
- Technology type
- Contract availability
Who should use this report?
Corporate Development teamsIdentify comparable asset acquisitions, active buyers and relevant transaction structures.
Business Development and Licensing teams
Evaluate asset purchase opportunities alongside licensing and other partnering alternatives.
Portfolio Strategy teams
Understand how companies use targeted asset acquisitions and divestments to reshape portfolios.
Companies Considering Asset Divestment
Identify organizations with a demonstrated appetite for comparable products, technologies or royalty interests.
Valuation and Finance teams
Investigate disclosed transaction economics and relevant precedent deals to support internal assessment.
Competitive and Market Intelligence teams
Track which assets companies are acquiring and how competitors are using asset purchases to strengthen portfolios.
Legal and Transaction teams
Review publicly available asset purchase agreements and precedent provisions to support transaction preparation and negotiation.
Turn market-wide asset acquisition intelligence into company-specific insight
For qualifying customers, the analyst can also provide a Customized Executive Partnering Briefing alongside the report.The briefing applies the underlying asset purchase intelligence to the customer's own acquisition, divestment, product or portfolio objectives.
Depending on requirements, this can include relevant comparable transactions, prospective buyers or sellers, competitor acquisition activity, asset-type analysis, financial benchmarks, contract insights and other intelligence selected specifically for the client's situation.
Table of Contents
Executive SummaryChapter 1 - Introduction
Chapter 2 - Trends in asset purchase dealmaking
Chapter 3 - Overview of asset purchase deal structure
Chapter 4 - Leading asset purchase deals
Chapter 5 - Top 25 most active asset purchase dealmakers
Chapter 6 - Asset purchase deals including contracts directory
Deal directory
TABLE OF FIGURES
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3B Pharmaceuticals
- 3CL Sciences
- 3M
- 4D Molecular Therapeutics
- 9 Meters Biopharma
- 23andMe
- 30 Technology
- Aadi Bioscience
- Aardvark Therapeutics
- Abbvie
- Abcam
- AbCellera Biologics
- Acacia Research
- Accelus
- Accure Therapeutics
- Achaogen
- AC Immune
- Acino Pharma
- Aclaris Therapeutics
- Acorda Therapeutics
- Acrotech Biopharma
- Actelion
- Actylis
- Acutus Medical
- Adalvo
- Adama
- Adamis Pharmaceuticals
- Adapsyn Bioscience
- Adaptas Solutions
- AdaptHealth
- Additive Orthopaedics
- Adello Biologics
- Adhera Therapeutics
- Adial Pharmaceuticals
- adMare BioInnovations
- Admedus
- Adovate
- Advanced BioMatrix
- Advanced Facialdontics
- Advanced Neural Dynamics
- Advanced Tear Diagnostics
- AdvanSource Biomaterials
- ADvantage Therapeutics
- Advanz Pharma
- Advent International
- Aegis Sciences
- Aelix Therapeutics
- Aesthetic Medical International
- Aethon Therapeutics
- Aevitas Therapeutics
- AFFiRiS
- AgBiome
- AGC Biologics
- Agenus Bio
- Agios Pharmaceuticals
- Agno Pharma
- AirNexis Therapeutics
- Ajinomoto Bio-Pharma Services
- Akebia Therapeutics
- Akida
- Akorn
- Alaya.bio
- Alcon Laboratories
- Alcyone Therapeutics
- Aleafia Health
- Aleph Farms
- Alexion Pharmaceuticals
- Alfasigma
- Alfred E. Mann Institute for Biomedical Engineering
- Algernon Pharmaceuticals
- ALK-Abello
- Allergan
- Allergan Aesthetics
- AllerQuest
- Alliance Pharma
- Ally Biotech
- Almirall
- Altaris Capital Partners
- Altarum Institute
- Altavant Sciences
- Alvogen
- Alvotech
- Amcor
- American Regent
- Amerigen Pharmaceuticals
- AmerisourceBergen
- Amgen
- AMMTeK
- Amneal Pharmaceuticals
- Ampersand Capital Partners
- Amphastar Pharmaceuticals
- AmplifyBio
- Amplyx Pharmaceuticals
- Amylyx Pharmaceuticals
- Amyris
- Angelini Pharma
- Angiodynamics
- ANI Pharmaceuticals
- Anpac Bio-Medical Science
- Antares Pharma
- Antares Therapeutics
- Antylia Scientific
- Apeiron Biologics
- Apellis Pharmaceuticals
- ApoPharma
- Apotex
- Applied StemCell
- Applied UV
- Aradigm
- Araris Biotech
- aratinga.bio SAS Group
- Arcadia Biosciences
- Arcadia Consumer Healthcare
- Ardena
- argenx
- ArisGlobal
- Arivis
- Arkuda Therapeutics
- Arranta Bio
- Arrevus
- Arrowhead Pharmaceuticals
- ARS Pharmaceuticals
- Artisan Bio
- Arvinas
- Asana Biosciences
- Asarina Pharma
- Ascend Advanced Therapies
- Ascension
- Asklepios Biopharmaceutical
- Aspargo Laboratories
- Aspen Holding
- Aspen Pharmacare Canada
- Aspen Surgical Products
- Assembly Biosciences
- Assertio Therapeutics
- Assisi Animal Health
- Astellas Pharma
- Astorg Partners
- AstraZeneca
- Astrea Pharma
- Atara Biotherapeutics
- ATEC Spine
- Athenex
- AtlantiCare
- Atnahs Pharma
- ATP
- Atreca
- Attralus
- Audax Private Equity
- Augmedics
- AUG Therapeutics
- AuraGen Aesthetics
- Aurora Cannabis
- AuxoCell Laboratories
- Avacta
- Avalo Therapeutics
- Avanos Medical
- Avantor
- Avicanna
- Avrobio
- AXIM Biotechnologies
- Axonics
- AxoSim
- Ayala Pharmaceuticals
- Aytu BioPharma
- Azurity Pharmaceuticals
- Baktus
- Baptist Health Care
- Baring Private Equity Asia
- Basilea Pharmaceutica
- Bausch & Lomb
- Bausch Health Companies
- Bavarian Nordic
- Baxter International
- Bayer
- Bayer Animal Health
- Baystate Health
- B Braun
- Beacon Therapeutics
- Beartooth Therapeutics
- Beckley Psytech
- Becton Dickinson
- Beiersdorf
- Bellicum Pharmaceuticals
- Bellin Health
- Bellus Health
- Belyntic
- Benuvia Therapeutics
- Benvenue Medical
- BetterLife Pharma
- Bigfoot Biomedical
- Bio-Rad Laboratories
- bioAffinity Technologies
- BioAnalytical Systems
- Bioceres
- BioClinica
- Biocon
- BioDelivery Sciences
- Biodelta Nutraceuticals
- Biodesix
- BioDuro
- Biofrontera Pharma
- Biogen
- BioGene Technology
- Bio Innovation Group
- BioMarin Pharmaceutical
- BioMedion
- bioMerieux
- BioMotiv
- Bioness
- BioNTech
- BioNxt Solutions
- BiopharmX
- Biora Therapeutics
- BioReference Laboratories
- BioSig Technologies
- Biossil
- BioStem Technologies
- BioSyent
- Biosynth
- BioTech Medics
- BioTelemetry
- BioTissue
- Biotronik
- BioVaxys
- Bioventus
- BioVie
- Blood and Plasma Research
- Bluebird Bio
- Blue Water Biotech
- Blue Water Vaccines
- Blumentech
- BMG Pharmaceuticals
- Boehringer Ingelheim
- Bolt Biotherapeutics
- Bone Therapeutics
- Bora Pharmaceuticals
- Boryung Pharmaceutical
- Boston Pharmaceuticals
- Boston Scientific
- Botanix Pharmaceuticals
- BoxView
- BriaCell Therapeutics
- BriaPro Therapeutics
- Brickell Biotech
- BridgeBio Pharma
- Bridge Medicines
- Bridge to Life
- Bridgewest Group
- Briggs Healthcare
- Brii Biosciences
- Bristol-Myers Squibb
- Bruker
- BVI Medical
- C2Dx
- Cadrenal Therapeutics
- Calibre Scientific
- Cambus Medical
- CanAm Bioresearch
- Candel Therapeutics
- Cannabis Manufacturer’s Guild
- Cannara Biotech
- Cantargia
- Cardinal Health
- CardioFocus
- Cardionomic
- Cardiovascular Systems
- Care Access Research
- Carestream Health
- Carisma Therapeutics
- Carterra
- Castle Biosciences
- Catalent
- Catalyst Biosciences
- Catalyst Pharmaceuticals
- Catheter Precision
- CBC Group
- Cedars-Sinai Medical Center
- Celator
- Celgene
- Cell Biosciences
- Celling Biosciences
- Cellistic
- CellReady
- Celltrion
- Celsee
- Celularity
- Celyad
- Celyn Therapeutics
- CEM
- Centene
- Centinel Spine
- Centre for Probe Development and Commercialization
- CeraVx
- Cerebain Biotech
- Cerecor
- Cerner
- Certara
- Change Healthcare
- Charles River Laboratories
- Chembio Diagnostics
- Chemomab Therapeutics
- Chemours Company
- Cheplapharm Arzneimittel
- Chiesi Farmaceutici
- Chimagen Biosciences
- China Pharma Holdings
- Cilag AG
- Cinven
- Cipher Pharmaceuticals
- Cipla
- Circadian Wellness
- Cirrus Dx
- Cisbio Bioassays
- Clarion Medical Technologies
- Clarus Therapeutics
- Clayton Dubilier & Rice
- Clovis Oncology
- Co.Don
- Codan Triplus
- Codexis
- Codiak BioSciences
- Coeptis Pharmaceuticals
- Coherus Biosciences
- College Park Industries
- Collegium Pharmaceuticals
- Community Health Systems
- Concert Pharmaceuticals
- Confluent Medical Technologies
- ConforMIS
- Conmed
- Context Therapeutics
- ConvaTec
- Conventus Orthopaedics
- Cook Medical
- Cooper Companies
- Coram
- Cord Blood Registry
- Corden Pharma
- Cordis
- CorDynamics
- Corium International
- Corium Therapeutics
- Corning
- CORXEL Pharmaceuticals
- Corza Health
- Corza Medical
- Cosette Pharmaceuticals
- Covance
- Covestro
- Covetrus
- Covis Pharmaceutical
- Covistat
- Crinetics
- CROMA Pharma
- Crosswalk Therapeutics
- Crown Bioscience
- Cryolife
- CTI BioPharma
- Cubex
- Cullinan Oncology
- Cumberland Emerging Technologies
- Curaleaf
- Curi Bio
- Curon Biopharmaceutical
- Cybin
- Cyclerion Therapeutics
- CYduct Diagnostics
- Cynata Therapeutics
- Cyprium Therapeutics
- Cytek Biosciences
- Cytokinetics
- CytoMed Therapeutics
- Daiichi Sankyo
- Danaher
- Dascena
- DAS Therapeutics
- Day Zero Diagnostics
- Dechra Pharmaceuticals
- DeciBio Consulting
- Delpharm
- Denovo Biopharma
- Dentsply International
- DermaPort
- Dermira
- DermOQ
- Desert Medical Campus
- Desma HC
- DeuteRx
- Dexcel Pharma
- DiagnaMed
- DiamiR
- DifGen Pharmaceuticals
- Dilon Diagnostics
- Dimerix Biosciences
- Discovery Life Sciences
- Diversey Care
- DJO Surgical
- Dong-A Pharmaceutical
- Dr. Reddy's Laboratories
- Dren Bio
- DSM
- DSM Nutritional Products
- Dualogics
- Duke University Health System
- Dune Medical Devices
- Durect
- Dutch Emotional Brain
- EaglePicher Technologies
- Easy Hundred
- Eckert & Ziegler
- Ecolab
- Edan Diagnostics
- Eddingpharm
- Eden Biologics
- Edgewise Therapeutics
- EdiGene
- Edison Nation
- Editas Medicine
- Edwards Lifesciences
- Ehave
- Eiger BioPharmaceuticals
- E Ink
- Elanco
- Electrical Geodesics
- Elekta
- Elektron Eye Technology
- Eli Lilly
- ELT Sight
- Eluminex Biosciences
- Emboline
- Emerald Health Therapeutics
- Emergent BioSolutions
- Emmes
- Empyrean Medical Systems
- Encore Medical
- EndoCeutics
- Endogastric Solutions
- Endonovo Therapeutics
- Endo Ventures
- Enko
- Enodia Therapeutics
- Entheon Biomedical
- Envigo
- Environmental Tectonics Corporation
- Envista
- EnWave
- Enzyvant Science
- Epigenomics
- EPI Health
- Eppendorf
- Equillium
- Erytech Pharma
- Essential Pharma
- Essential Pharmaceuticals
- Esteve
- Eterna Therapeutics
- Ethicon Endo-Surgery
- Eton Pharmaceuticals
- Eurobio Scientific
- Evah
- Everest Medicines
- Evonik Industries
- Evoqua Water Technologies
- Evox Therapeutics
- Exacis Biotherapeutics
- Exelixis
- Expedeon
- Eyevance
- Factor Bioscience
- FairJourney Biologics
- Fairlong Capital
- Federation Bio
- Finch Therapeutics
- Firsthand Technology
- Flagship Biosciences
- Flamma
- FORMA Therapeutics
- Fox Chase Chemical Diversity Center
- Freedom Innovations
- Fresh Tracks Therapeutics
- Freudenberg Medical
- Freya Pharma Solutions
- Frontage Laboratories
- Fujifilm
- Fujifilm Diosynth Biotechnologies
- Fusion Pharmaceuticals
- G&W Laboratories
- Galapagos
- Galderma
- Galecto
- Galera Therapeutics
- Galgo Medical
- Galvanize Therapeutics
- GamaMabs Pharma
- Gardia Medical
- GC Pharma
- GE Healthcare
- Genentech
- GenePOC
- Genesis MedTech
- Genezen
- Genomadix
- Genomic Health
- Genovac
- Germfree
- Gilead Sciences
- Gilgamesh Pharmaceuticals
- Ginkgo BioWorks
- GI Reviewers
- Givaudan
- GL Capital Group
- Glenmark Pharmaceuticals
- Glycotope Biotechnology
- Gossamer Bio
- Gowan Crop Protection
- GPI Group
- Gravitas Therapeutics
- Great Belief International
- Greenlight Biosciences
- Greenteaspoon
- GRI Bio
- Grifols
- Grunenthal
- GSK
- GT Biopharma
- GT Medical Technologies
- Gurnet Point Capital
- GVS
- Gyrus Capital
- H-CYTE
- Hackensack University Medical Center
- Haemonetics
- Haisco Pharmaceutical
- Halo Labs
- Harmonic Bionics
- Harrow Health
- Harvard University
- Havn Life Sciences
- HCA Healthcare
- Healeon Medical
- Healion Bio
- Healiva
- Health Outcomes Sciences
- HealthTrackRx
- HeartBeam
- HeavenlyRx
- heliosDX
- Hellman & Friedman
- Hera Biotech
- Heritage Group
- Heritage Pharmaceuticals
- Heska
- High Ridge Brands
- Hikma Pharmaceuticals
- Hill-Rom
- Hillstream BioPharma
- HLS Therapeutics
- HMNRTH
- Hologic
- Horizon Discovery
- Howard Foundation
- Howmedica Osteonics
- HS Pharmaceuticals
- HTL Biotechnology
- Hubertus Apotheke am Salzufer
- Hubro Therapeutics
- Huifeng Bio-Pharmaceutical Technology
- Humanetics
- Humanitas University
- Hunt Valley PharmaLAB
- Hutchinson Technology
- Hutchison China MediTech
- Hypera Pharma
- I-mab
- iAnthus Capital
- IASO Biotherapeutics
- IBA
- iCAD
- Icagen
- IconOVir Bio
- IDEAYA Biosciences
- Idorsia
- IFM Therapeutics
- Iktos
- IlmixGroup
- ImaginAb
- Imagin Medical
- Immedica
- ImmunGene
- ImmunityBio
- ImmunoCellular Therapeutics
- Immunome
- Imugene
- IMV
- Inceptor Bio
- Incyte
- Indivumed
- INEX Innovate
- Infab
- InflammX Therapeutics
- Innate Pharma
- Innovation Skane
- Innovative Cellular Therapeutics
- Innovent Biologics
- Inovet
- Inozyme Pharma
- Inserm
- In Silico Biosciences
- Inspirata
- Institut du Cancer Courlancy
- Insulet
- Intas Pharmaceuticals
- Intavis Bioanalytical Instruments
- Integra LifeSciences
- Integrated DNA Technologies
- Integrated Proteomics Applications
- Integrative Medicine
- IntegriChain
- Intermountain Precision Genomics
- International Biomedical
- International Isotopes
- International Process Plants
- Interpace BioPharma
- IntraFuse
- Invitae
- Ionic Brands
- Ipsen
- iQ Group
- IQVIA
- iRenix Medical
- Iridex
- Irras
- Isologic Innovative Radiopharmaceuticals
- IsoPlexis
- IsoRay
- Itamar Medical
- Iveric Bio
- Ixaka
- Jackson Laboratory
- JAMP Pharma Group
- Janssen Biotech
- Janssen Pharmaceuticals
- Janssen Pharmaceutica NV
- Jefferson Healthcare
- Jerome Stevens Pharmaceuticals
- Johnson Matthey
- John Wiley and Sons
- Jolt Health
- Journey Medical
- JSR Life Sciences
- JT Pharmaceuticals
- Juvise Pharmaceuticals
- KabaFusion
- Kaerus Bioscience
- Kairos Pharma
- Kaken Pharmaceutical
- Kala Pharmaceuticals
- Kamada
- Kancera
- Kane Biotech
- Kantar Health
- Kanvas Biosciences
- Kapoose Creek Bio
- Karo Pharma
- Kartos Therapeutics
- Kashiv BioSciences
- KBP BioSciences
- KD Pharma
- Kedrion
- KemPharm
- Kensing
- Kezar Life Sciences
- Kincell Bio
- Kindred Bio
- Kindstar Globalgene Technology
- Kinnate Biopharma
- Kite Pharma
- Klogenix
- Klotho Neurosciences
- Kohlberg Kravis Roberts (KKR)
- Korsch
- Kronos Bio
- Kuros Biosciences
- Kyocera
- L3Harris Technologies
- Laboratoires DELBERT
- Laboratoire Serb
- Laboratoires Thea
- Laboratorio Medinfar
- Laboratorios Rubio
- Laboratory Corporation of America
- Laborie Medical Technologies
- Lafayette Instrument Company
- La Jolla Institute for Allergy & Immunology
- Landos Biopharma
- Lannett
- Lantheus Holding
- Lanxess
- Lanzhou Ion Therapy
- Legacy Health
- LeMaitre Vascular
- LENZ Therapeutics
- LEO Pharma
- Les Laboratoires Servier
- Lexicon Pharmaceuticals
- LGC
- LGM Pharma
- LI-COR Biosciences
- LIC Automation
- Lifecycle Biotechnologies
- Lifenet
- Ligand Pharmaceuticals
- Lighthouse Pharmaceuticals
- Liminal BioSciences
- Lincotek Medical
- LindaCare
- Lineage Cell Therapeutics
- LineaRx
- Link Fund Solutions
- Link Immunotherapeutics
- LivaNova
- Livestock Improvement
- LIVMOR
- LivNao Technologies
- Lobe Sciences
- Lobesity Pharma
- Longitude Capital
- Lonza
- Lorem Vascular
- LOTTE
- LSNE Contract Manufacturing
- LTL Pharma
- LTS Lohmann Therapie-Systeme
- Lucy Scientific Discovery
- Lumenis
- Luminera
- Luminex
- LuminUltra
- LumiraDx
- LumiThera
- Lumos Pharma
- Lyell Immunopharma
- MAB Discovery
- MabVax Therapeutics
- Macrogen
- Macrogenics
- MacuHealth
- MacuLogix
- Magstim
- Mainz Biomed
- Mandos
- MannKind Biopharmaceuticals
- Maravai LifeSciences
- Marinus Pharmaceuticals
- Marker Therapeutics
- Masimo
- Mati Therapeutics
- Matrox
- MAWD Pathology
- Maxima Pharmaceuticals
- Mayne Pharma
- MC10
- McKesson
- MD Anderson Cancer Center
- MDNA Life Sciences
- MDxHealth
- Medican Enterprises
- Medicom
- Medicure
- Medidata Solutions
- Medimetrics
- Medisca
- Medline
- Mednax
- Medtronic
- Megadalton Solutions
- Meilleur Technologies
- MeiraGTx
- Meitheal Pharmaceuticals
- Melinta Therapeutics
- Memo Therapeutics
- Menarini Asia-Pacific
- Mentice
- Merck and Co
- Merck Animal Health
- Merck KGaA
- Meridian Bioscience
- Merit Medical Systems
- Merrimack Pharmaceuticals
- Merz Therapeutics
- Mesa Laboratories
- Micro-Tech Endoscopy
- Microba Life Sciences
- Microbot Medical
- MiGenTra
- Mikart
- MilliporeSigma
- Minapharm
- Mind Medicine
- Minerva Surgical
- Mirum Pharmaceuticals
- Mission Therapeutics
- MITEM PHARMA
- Mithra Pharmaceuticals
- Mitralign
- Mitsubishi Chemical
- Mitsubishi Tanabe Pharma
- MLase
- MMT Technologies
- Moberg Pharma
- Modernizing Medicine
- Modern Meadow
- Modulus Therapeutics
- Molecular Assemblies
- MolecuLight
- Molnlycke Health Care
- Momentis Surgical
- Montagu Private Equity
- MorphoSys
- Mountain Valley MD
- MSD Animal Health
- MTD
- Mubadala Investment Company
- Mucokinetica
- Mustang Bio
- Myconic Capital
- Mylan Laboratories
- MyLife Technologies
- Myonex
- Myovant Sciences
- Myriad Genetics
- Myricx Bio
- Naari Pharma
- Nabriva Therapeutics
- Nanjing King-friend Biochemical Pharmaceutical
- NanoProteagen
- NantHealth
- Natera
- National Resilience
- Navidea Biopharmaceuticals
- NEC OncoImmunity
- Negev Labs
- Nektar Therapeutics
- NEMO Health
- Neogen
- Neograft Technologies
- Neosurgical
- NeoSync
- Nephron Pharmaceuticals
- Neptune Wellness Solutions
- Nestle
- Nestle Health Science
- NeuBase Therapeutics
- Neuraxpharm
- NeurMedix
- Neuro-Kinesis Corporation
- NeuroBo Pharmaceuticals
- Neuropathix
- Nevakar
- New Day Diagnostics
- Newport Research
- New York Blood Center
- Nexelis
- NEXGEL
- Nexgen Pharma
- Nextmune
- Nido Surgical
- Nika Pharmaceuticals
- NImmune Biopharma
- Nines
- Nitiloop
- NLC Pharma
- NOHO
- Noramco
- Nora Pharma
- Nordson Corporation
- North American Partners in Anesthesia
- NorthX Biologics
- Noscendo
- NovaBay Pharmaceuticals
- NovAccess Global
- Novan
- Novartis
- Novasep
- Novavax
- Novelion Therapeutics
- Noventia Pharma
- NovImmune
- Novogy
- Novo Nordisk
- Nuclera
- Nufarm
- Nutriband
- Nuvalent
- NYU Langone Medical Center
- Oakrum Pharma
- ObsEva
- Octant
- Ocugen
- Oculis
- Odyssey Health
- OhioHealth
- Omeros
- Oncimmune
- Oncopeptides
- OncoQuest
- Onkos Surgical
- Ono Pharmaceutical
- OpenBiome
- OpenGate Capital
- OPKO Health
- Opus Genetics
- Oragenics
- Orbimed Advisors
- Orexo
- Organon
- Organovo
- Orgenesis
- Orifarm
- Orion
- Orlando Health
- Orphazyme
- Orsenix
- Orthofix Medical
- Orum Therapeutics
- OSE Immunotherapeutics
- OSR Holdings
- OsteoCentric Technologies
- OS Therapies
- Otonomy
- Otsuka
- Otsuka America Pharmaceutical
- Ouro Medicines
- Ovid Therapeutics
- P3 Health
- Pacira Biosciences
- PACT Pharma
- Padagis
- Palatin Technologies
- Palisade Bio
- PanGenomic Health
- PanTheryx
- Paragon 28
- ParaPRO
- Parexel
- Pascal Biosciences
- Passage Bio
- Patagonia Pharmaceuticals
- PathAI
- PaxMedica
- Peak Rock Capital
- Pearsanta
- PEAR Therapeutics
- Pelthos Therapeutics
- PENTAX Medical
- PentixaPharm
- Performance Health
- Perfuse Therapeutics
- Periphagen Holdings
- Perrigo
- Perry Baromedical
- Perspective Therapeutics
- PetIQ
- Pfizer
- Pharmaceutical Associates
- Pharmacolog
- PharmaLogic
- Pharma Logistics
- Pharmanovia
- Pharmapar
- Pharmaron
- PharmaTher
- PhaseBio Pharmaceuticals
- PHC Holdings
- Phenomics Health
- Phoenixus
- Photonamic GmbH
- Physician Recommended Nutriceuticals
- Pierre Fabre
- Pierrel
- Piramal
- Pixium Vision
- PKG
- Plus Therapeutics
- PLx Pharma
- PMC Group
- Pocono Coated Products
- Poolbeg Pharma
- Poxel
- Precera Bioscience
- Precisa Medical Instruments
- Precision Biomonitoring
- Precision Neuroscience
- Precision Pathology Services
- PrepMD RMS
- Pressure BioSciences
- Prestige Consumer Healthcare
- PreveCeutical Medical
- Primavera Capital Group
- Prisma Health
- ProBioGen
- ProciseDx
- Progenics Pharmaceuticals
- Progenity
- ProKidney
- Proliant Health and Biologicals
- ProMed Pharma LLC
- Promius Pharma
- Propel Labs
- Propel Orthodontics
- ProQR Therapeutics
- Proteor
- Proteus Digital Health
- Prothelia
- Prothena
- Providence
- Psomagen
- Pulmokine
- Puration
- PureTech Health
- Purnovate
- Q2 Solutions
- Q32 Bio
- QIAGEN
- QPS
- Quadrifolia Management
- Qualigen
- Quasar Medical
- Quest Diagnostics
- Quince Therapeutics
- R1 RCM
- Radian
- Radius Health
- Rafarma Pharmaceuticals
- Rakuten Medical
- Ra Medical Systems
- Rasna Therapeutics
- Rayner Surgical
- RaySearch Laboratories
- Real Brands
- Realm Therapeutics
- Recipharm
- Reckitt Benckiser
- Recordati
- Rediscovery Life Sciences
- RedPoint Medical3D
- Regeneron Pharmaceuticals
- ReGen Scientific
- Regor Therapeutics
- ReliefBand Technologies
- ReLive Biotechnologies
- Relmada Therapeutics
- Remix Therapeutics
- Renovis
- Repare Therapeutics
- Resilience
- Resonetics
- Respira Therapeutics
- Retinagenix
- Reverie Labs
- Revive Therapeutics
- Revo Squared
- Rexgenero
- Roam Analytics
- Roche
- Rockwell Medical
- Rohner
- Roivant Sciences
- Rosemont Pharmaceuticals
- RoundTable Healthcare Partners
- RoverMed BioSciences
- Royal Philips Electronics
- RTI Surgical
- Rumpus Therapeutics
- Safegard Medical
- Saladax Biomedical
- Salarius Pharmaceuticals
- Samsung Bioepis
- Samsung Biologics
- Sandoz
- Sangamo Therapeutics
- Sanofi
- Santen Pharmaceutical
- Sanuwave Health
- Saol Therapeutics
- Sarcomatrix Therapeutics
- Saringer Life Science Technologies
- Sarnova
- Sartorius Stedim Biotech
- Savant HWP
- Scailyte
- Scantox
- Schwazze
- Science 37
- Science Corporation
- Scion Solutions
- Scipher Medicine
- SciSparc
- Scorpius BioManufacturing
- Scynexis
- Sebacia
- Selenity Pharmaceuticals
- Seneca
- Sensus Healthcare
- Sentynl Therapeutics
- Septerna
- Serenity Bioworks
- Seres Therapeutics
- Seyltx
- Sharp Fluidics
- Sharps Technology
- Shenzhen Beimei Pharmaceuticals
- Shionogi
- Shoppers Drug Mart
- Shoreline Biosciences
- Shorla Oncology
- Sibannac
- Sienna Biopharmaceuticals
- Sientra
- Sigma Analytical Services
- Signati Medical
- Signet Healthcare Partneers
- Silk Road Therapeutics
- Silony Medical
- Simplyfeye
- Simtra BioPharma Solutions
- Sinclair Research
- Sirona Medical
- SIT Laboratorio Farmaceutico
- SK Capital Partners
- Skin Products
- Sloan Pharma
- SmartBreast
- Smith & Nephew
- Smithers Avanza
- SOCPRA Sciences Sante et Humaines
- SofPulse
- Sofregen Medical
- Sohm
- Sol-Gel
- Solvay
- Sonic Healthcare
- Sorrel Medical
- Sorse Technology
- Sosei
- Southern Research Institute
- Spacelabs Healthcare
- Spectrum Pharmaceuticals
- Spinal Elements
- SpineThera
- Spiral Therapeutics
- Sprint Bioscience
- Sproutly
- Spruce Biosciences
- Spry Health
- SQI Diagnostics
- STADA Arzneimittel
- Stanford Health Care
- Starboard Medical
- Stark Investments
- Steeper Group
- StemBioSys
- StemoniX
- Stericycle
- Steris Corporation
- Steward Health Care System
- STRATA Skin Sciences
- Stryker
- SugarLeaf Labs
- Sumitomo Dainippon Pharma
- Sumitovant Biopharma
- Summa Health System
- Summit Biolabs
- Summit Therapeutics
- SunMed
- Sun Pharmaceutical
- Sunstar Suisse
- SuperiorVAS
- Supernus Pharmaceuticals
- Surgalign
- SurgCenter Development
- SWAT Medical AB
- Swedish Orphan Biovitrum
- Synergy Pharmaceuticals
- Syngene
- Synhale Therapeutics
- Synnovation Therapeutics
- Synsight
- Syros Pharmaceuticals
- Tabula Rasa HealthCare
- Taiho
- Takeda Pharmaceutical
- Talaris Therapeutics
- Tamir Biotechnology
- Targovax
- Tarus Therapeutics
- Tecan
- TekCyte
- Tekni-Plex
- Teleflex
- Teligent
- Telix Pharmaceuticals
- Tempest Therapeutics
- Tenet Healthcare
- Terran Biosciences
- TerSera Therapeutics
- Terumo
- Teva Pharmaceutical Industries
- Teva Pharmaceuticals USA
- The DNA Company
- The Green Organic Dutchman Holdings
- Therabody
- Therakind
- TheraLight
- Therapeutic Solutions International
- Theravance Biopharma
- Theravant
- Therma Bright
- ThermiGen
- Thermo Fisher Scientific
- THINK Surgical
- Tilray
- Titan Medical
- Titan Pharmaceuticals
- Tivic Health Systems
- Tiziana Life Sciences
- TJ Biopharma
- Tocagen
- Todos Medical
- Tolmar
- Tonbo Biosciences
- TONIX Pharmaceuticals
- Topcon
- Torrey Pines Investment
- Transcend Biodynamics
- TransEnterix
- Transformative Biotech
- Transgene
- TransMedics
- Travere Therapeutics
- Treace Medical Concepts
- TrialSpark
- Trigemina
- TriLink BioTechnologies
- Trinity Biotech
- TriReme Medical
- TriRx Pharmaceutical Services
- Trod Medical
- Tubulis
- Tufts Medical Center
- TuHURA Biopharma
- TuHURA Biosciences
- Tulex Pharmaceuticals
- Turn Biotechnologies
- TwinStrand Biosciences
- uBiome
- uBriGene Biosciences
- UCB
- Undisclosed Company
- Unicycive Therapeutics
- UniQure
- United Immunity
- Universal Display
- University of Helsinki
- University of Texas
- Upsher-Smith
- Urgo Laboratories
- UroGen Pharma
- Urovant Sciences
- US Compounding
- US WorldMeds
- Valneva
- Valo Health
- Valo Therapeutics
- Varian Biopharmaceuticals
- Varian Medical Systems
- Vascular Graft Solutions
- Vault Health
- Vaximm
- Vaxxel
- VBI Vaccines
- VBL Therapeutics
- Vega Therapeutics
- Velocity Clinical Research
- Veralox Therapeutics
- Vera Therapeutics
- Vertex Pharmaceuticals
- Veru
- Vesigen Therapeutics
- Vetoquinol
- Viamet Pharmaceuticals
- Viatris
- Vibliome Therapeutics
- ViewPoint Therapeutics
- ViewRay
- Vifor Pharma
- Vimian Group
- Virbac
- Virox Technologies
- Viscogliosi Brothers
- Visus Therapeutics
- Vitatex
- Viveca Biomed
- Vivos Therapeutics
- Vtesse
- Vyaire Medical
- Vyant Bio
- Vyera Pharmaceuticals
- VYNE Therapeutics
- Walgreens
- Warburg Pincus
- Warp Drive Bio
- Waters Corporation
- Wave Neuroscience
- WavePoint Medical
- Webster Equity Partners
- Wellspring Ophthalmics
- Wesana Health
- West Pharmaceutical Services
- Windtree Therapeutics
- Wittenstein
- Wockhardt
- WraSer Pharmaceuticals
- Wuhan Humanwell
- WuXi Biologics
- Wuxi STA
- X-chem
- Xbiome
- XBiotech
- Xbrane Biopharma
- Xcelerate Solutions
- Xellia Pharmaceuticals
- Xoma
- Xspire Pharma
- Xtant Medical
- Xylo Technologies
- Yield10 Bioscience
- Yourgene Health
- Ypsomed
- Yumanity Therapeutics
- ZAP Surgical Systems
- Zealand Pharma
- Zebra technologies
- Zelgen
- Zentiva
- Zimmer Biomet
- Zoetis
- Zomedica
- Zydus Lifesciences
- Zymergen
- Zymeworks
- ZYUS Life Sciences
Methodology
- The publisher reports provide insight into the trends and terms of partnering deals in the global life sciences sector.
- The publisher reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.
- The publisher analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.
- The publisher reports source deal data from our proprietary deals and alliances database. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal.
- The data in the deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.
The publisher provides comprehensive coverage of the following partnering or deal types:
- Asset purchase
- Assignment
- Co-development
- Co-market
- Co-promotion
- Collaborative R&D
- Contract service
- CRADA
- Cross-licensing
- Development
- Distribution
- Equity purchase
- Evaluation
- Grant
- Joint venture
- Licensing
- Loan
- Manufacturing
- Marketing
- Option
- Promotion
- Research
- Royalty financing
- Settlement
- Spin out
- Sub license
- Supply
- Termination
- Warrant
Every deal record is fully categorized and includes the following data, where available:
- Industry sector
- Therapy areas
- Technology type
- Deal components
- Financial terms
- Stage of development
- Exclusivity
- Asset type
- Geographic focus
- Excluded geography
- Company press release
- SEC filing data including contract document
All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.
LOADING...
